A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas

Author： Kim Seok   Kang Hye   Kim Jin   Eom Hyeon-Seok   Huh Jooryung   Ko Young   Lee Jongtae   Yim Dong-Seok   Lee Soo-Youn   Park Weon   Yang Woo   Lee Seung-Sook   Suh Cheolwon   Kim Won  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.31, Iss.6, 2013-12, pp. : 1514-1521

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel treatment avenues for peripheral T-cell lymphomas

By Hopfinger Georg   Griessl Robert   Sifft Eveline   Taylor Ninon   Kenner Lukas   Greil Richard   Merkel Olaf  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 12, 2012-12 ,pp. : 1149-1163

Informa Healthcare

Access to resources Recommend Favorite

Impact of comorbidity on survival in peripheral T‐cell lymphomas: A Swedish Lymphoma Registry study

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 159-165

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alternating R‐CHOP and R‐cytarabine is a safe and effective regimen for transplant‐ineligible patients with a newly diagnosed mantle cell lymphoma

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 110-115

John Wiley & Sons Inc

Access to resources Recommend Favorite

Emerging drugs in cutaneous T-cell lymphomas

By Dummer Reinhard  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 381-392

Informa Healthcare

Access to resources Recommend Favorite

New Targets of Therapy in T-Cell Lymphomas

By  

Current Drug Targets, Vol. 11, Iss. 4, 2010-04 ,pp. : 482-493

Bentham Science Publishers

Access to resources Recommend Favorite